Graded
The US health department published a draft policy under which it would not act against pharmacies that make BPC-157 on a prescription for a named patient, until the FDA decides by rule. It is still not an approved medicine.
PL

AOD-9604

hGH 176-191 · Tyr-hGH(177-191)

A changed fragment of human growth hormone, developed as an obesity drug. No such medicine exists, and there are no studies with random groups.

This site is for information and education only. It does not promote or encourage the use or purchase of the substances described and is not medical advice. Many are not authorised as medicines and their safety has not been established. We sell nothing and have no ties to sellers. For health decisions, consult a doctor.

Type
Peptide
Stage
Work stopped
Safety
Not known
Doping
Banned in sport, WADA 2026
Risk of fakes
Medium
Checked
Not yet

Safety. There are no studies with random groups. A 2026 review says very little is known about the safety of peptides like this one in people. Sources: study 1.

Risk of fakes. Reviews name it among peptides sold outside medical care. We found no tests of what these products contain. Sources: study 1.

Is it legal

How much research exists

Scientific papers
22
Studies with random groups
0
Registered studies in people
0

These are search results. A count shows how much exists, not how good the studies are. 1 Nov 2026.

What studies show

  • DFat loss

    Not clear. Obese rats gained less weight. There are no studies with random groups in people.

Reported side effects

What doctors, patients and companies reported to the US medicines agency (FDA), and single cases described in medical journals. A report says what happened to someone after taking the substance. It does not prove the substance caused it, and it does not say how often it happens. Reports do not change any grade.

Reports to the FDA (USA)

Reports
0
Of these, serious
0

The FDA has no reports. That is not a sign of safety: almost nobody reports substances from outside pharmacies.

Cases described in medical journals

We found no published case of harm.

FDA reports come from openFDA, cases from a PubMed search. The editors have not read these cases yet. Titles stay in the original language. As of 3 Nov 2026.

Studies we have read

StudiesKind of studyWho was studiedPeopleDurationDose as studiedWho paid
Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone.Hormone research 2000In animalsrats, Obese Zucker rats–3 wk–Unknown

More papers we found

We found these papers automatically in PubMed. The editors have not read them yet, and they do not affect any grade. Titles stay in the original language.

All papers and studies we found (18)

Short answers

Does AOD-9604 work?
A changed fragment of human growth hormone, developed as an obesity drug. No such medicine exists, and there are no studies with random groups. Fat loss: grade D, not clear. Obese rats gained less weight. There are no studies with random groups in people.
Is AOD-9604 legal?
PL: No approval. The European medicines database (EMA) lists no such medicine in Poland (9 October 2026). The Polish register was down, so we could not check it directly. EU: No approval. The European medicines database (EMA), which covers EU and national approvals, lists no such medicine (9 October 2026). US: No approval. The FDA drug register has no such medicine.
Is AOD-9604 banned in sport?
Banned in sport, WADA 2026.
Is AOD-9604 safe?
Not known. There are no studies with random groups. A 2026 review says very little is known about the safety of peptides like this one in people.

Plain text for machines